Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.51 USD | +2.33% |
|
+1.15% | +28.57% |
Jun. 13 | Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial | CI |
May. 20 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.57% | 29.16M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- LSTA Stock
- News Lisata Therapeutics, Inc.
- Transcript : Lisata Therapeutics, Inc., 2023 Earnings Call, Feb 29, 2024